 | • レポートコード：GIR-2104Z09064 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、黒色腫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。黒色腫治療の種類別市場規模（化学療法、免疫療法、標的療法、放射線療法、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・黒色腫治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Amgen, Inc.、Roche.、Bristol-Myers Squibb Company、Novartis AG、Merck & Co., Inc.、Daiichi Sankyo Company, Limited、AB Sciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：化学療法、免疫療法、標的療法、放射線療法、その他 ・用途別分析2016年-2026年：病院、診療所、その他 ・黒色腫治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・黒色腫治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・黒色腫治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・黒色腫治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・黒色腫治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Melanoma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Melanoma Therapeutics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Melanoma Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Melanoma Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy
Others
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
AstraZeneca
Amgen, Inc.
Roche.
Bristol-Myers Squibb Company
Novartis AG
Merck & Co., Inc.
Daiichi Sankyo Company, Limited
AB Sciences
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Melanoma Therapeutics
1.2 Classification of Melanoma Therapeutics by Type
1.2.1 Overview: Global Melanoma Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Melanoma Therapeutics Revenue Market Share by Type in 2020
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.2.7 Others
1.3 Global Melanoma Therapeutics Market by Application
1.3.1 Overview: Global Melanoma Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Melanoma Therapeutics Market Size & Forecast
1.5 Global Melanoma Therapeutics Market Size and Forecast by Region
1.5.1 Global Melanoma Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Melanoma Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Melanoma Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Melanoma Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Melanoma Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Melanoma Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Melanoma Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Melanoma Therapeutics Market Drivers
1.6.2 Melanoma Therapeutics Market Restraints
1.6.3 Melanoma Therapeutics Trends Analysis
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Melanoma Therapeutics Product and Solutions
2.1.4 AstraZeneca Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Amgen, Inc.
2.2.1 Amgen, Inc. Details
2.2.2 Amgen, Inc. Major Business
2.2.3 Amgen, Inc. Melanoma Therapeutics Product and Solutions
2.2.4 Amgen, Inc. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amgen, Inc. Recent Developments and Future Plans
2.3 Roche.
2.3.1 Roche. Details
2.3.2 Roche. Major Business
2.3.3 Roche. Melanoma Therapeutics Product and Solutions
2.3.4 Roche. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche. Recent Developments and Future Plans
2.4 Bristol-Myers Squibb Company
2.4.1 Bristol-Myers Squibb Company Details
2.4.2 Bristol-Myers Squibb Company Major Business
2.4.3 Bristol-Myers Squibb Company Melanoma Therapeutics Product and Solutions
2.4.4 Bristol-Myers Squibb Company Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Melanoma Therapeutics Product and Solutions
2.5.4 Novartis AG Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Novartis AG Recent Developments and Future Plans
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business
2.6.3 Merck & Co., Inc. Melanoma Therapeutics Product and Solutions
2.6.4 Merck & Co., Inc. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck & Co., Inc. Recent Developments and Future Plans
2.7 Daiichi Sankyo Company, Limited
2.7.1 Daiichi Sankyo Company, Limited Details
2.7.2 Daiichi Sankyo Company, Limited Major Business
2.7.3 Daiichi Sankyo Company, Limited Melanoma Therapeutics Product and Solutions
2.7.4 Daiichi Sankyo Company, Limited Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Daiichi Sankyo Company, Limited Recent Developments and Future Plans
2.8 AB Sciences
2.8.1 AB Sciences Details
2.8.2 AB Sciences Major Business
2.8.3 AB Sciences Melanoma Therapeutics Product and Solutions
2.8.4 AB Sciences Melanoma Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AB Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Melanoma Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Melanoma Therapeutics Players Market Share
3.2.2 Top 10 Melanoma Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Melanoma Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Melanoma Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Melanoma Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Melanoma Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Melanoma Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Melanoma Therapeutics Revenue by Type (2016-2026)
6.2 North America Melanoma Therapeutics Revenue by Application (2016-2026)
6.3 North America Melanoma Therapeutics Market Size by Country
6.3.1 North America Melanoma Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Melanoma Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Melanoma Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Melanoma Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Melanoma Therapeutics Revenue by Type (2016-2026)
7.2 Europe Melanoma Therapeutics Revenue by Application (2016-2026)
7.3 Europe Melanoma Therapeutics Market Size by Country
7.3.1 Europe Melanoma Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Melanoma Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Melanoma Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Melanoma Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Melanoma Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Melanoma Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Melanoma Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Melanoma Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Melanoma Therapeutics Market Size by Region
8.3.1 Asia-Pacific Melanoma Therapeutics Revenue by Region (2016-2026)
8.3.2 China Melanoma Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Melanoma Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Melanoma Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Melanoma Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Melanoma Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Melanoma Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Melanoma Therapeutics Revenue by Type (2016-2026)
9.2 South America Melanoma Therapeutics Revenue by Application (2016-2026)
9.3 South America Melanoma Therapeutics Market Size by Country
9.3.1 South America Melanoma Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Melanoma Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Melanoma Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Melanoma Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Melanoma Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Melanoma Therapeutics Market Size by Country
10.3.1 Middle East & Africa Melanoma Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Melanoma Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Melanoma Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Melanoma Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Melanoma Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Melanoma Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Melanoma Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Melanoma Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Melanoma Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Melanoma Therapeutics Product and Solutions
Table 9. AstraZeneca Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amgen, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Amgen, Inc. Major Business
Table 12. Amgen, Inc. Melanoma Therapeutics Product and Solutions
Table 13. Amgen, Inc. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche. Corporate Information, Head Office, and Major Competitors
Table 15. Roche. Major Business
Table 16. Roche. Melanoma Therapeutics Product and Solutions
Table 17. Roche. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 19. Bristol-Myers Squibb Company Major Business
Table 20. Bristol-Myers Squibb Company Melanoma Therapeutics Product and Solutions
Table 21. Bristol-Myers Squibb Company Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 23. Novartis AG Major Business
Table 24. Novartis AG Melanoma Therapeutics Product and Solutions
Table 25. Novartis AG Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Merck & Co., Inc. Major Business
Table 28. Merck & Co., Inc. Melanoma Therapeutics Product and Solutions
Table 29. Merck & Co., Inc. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Daiichi Sankyo Company, Limited Corporate Information, Head Office, and Major Competitors
Table 31. Daiichi Sankyo Company, Limited Major Business
Table 32. Daiichi Sankyo Company, Limited Melanoma Therapeutics Product and Solutions
Table 33. Daiichi Sankyo Company, Limited Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AB Sciences Corporate Information, Head Office, and Major Competitors
Table 35. AB Sciences Major Business
Table 36. AB Sciences Melanoma Therapeutics Product and Solutions
Table 37. AB Sciences Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Melanoma Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 39. Global Melanoma Therapeutics Revenue Share by Players (2019-2021)
Table 40. Breakdown of Melanoma Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Melanoma Therapeutics Players Head Office, Products and Services Provided
Table 42. Melanoma Therapeutics Mergers & Acquisitions in the Past Five Years
Table 43. Melanoma Therapeutics New Entrants and Expansion Plans
Table 44. Global Melanoma Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 45. Global Melanoma Therapeutics Revenue Share by Type (2016-2021)
Table 46. Global Melanoma Therapeutics Revenue Forecast by Type (2021-2026)
Table 47. Global Melanoma Therapeutics Revenue by Application (2016-2021)
Table 48. Global Melanoma Therapeutics Revenue Forecast by Application (2021-2026)
Table 49. North America Melanoma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Melanoma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Melanoma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Melanoma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Melanoma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Melanoma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Melanoma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Melanoma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Melanoma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Melanoma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Melanoma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Melanoma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Melanoma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Melanoma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Melanoma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Melanoma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Melanoma Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Melanoma Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Melanoma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Melanoma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Melanoma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Melanoma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Melanoma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Melanoma Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Melanoma Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Melanoma Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Melanoma Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Melanoma Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Melanoma Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Melanoma Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Melanoma Therapeutics Picture
Figure 2. Global Melanoma Therapeutics Revenue Market Share by Type in 2020
Figure 3. Chemotherapy
Figure 4. Immunotherapy
Figure 5. Targeted Therapy
Figure 6. Radiation Therapy
Figure 7. Others
Figure 8. Melanoma Therapeutics Revenue Market Share by Application in 2020
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Melanoma Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Melanoma Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Melanoma Therapeutics Revenue Market Share by Region (2016-2026)
Figure 15. Global Melanoma Therapeutics Revenue Market Share by Region in 2020
Figure 16. North America Melanoma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Melanoma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Melanoma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Melanoma Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Melanoma Therapeutics Market Drivers
Figure 21. Melanoma Therapeutics Market Restraints
Figure 22. Melanoma Therapeutics Market Trends
Figure 23. AstraZeneca Recent Developments and Future Plans
Figure 24. Amgen, Inc. Recent Developments and Future Plans
Figure 25. Roche. Recent Developments and Future Plans
Figure 26. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 27. Novartis AG Recent Developments and Future Plans
Figure 28. Merck & Co., Inc. Recent Developments and Future Plans
Figure 29. Daiichi Sankyo Company, Limited Recent Developments and Future Plans
Figure 30. AB Sciences Recent Developments and Future Plans
Figure 32. Global Melanoma Therapeutics Revenue Share by Players in 2020
Figure 33. Melanoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Melanoma Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Melanoma Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Melanoma Therapeutics Revenue Share by Type in 2020
Figure 38. Global Melanoma Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Melanoma Therapeutics Revenue Share by Application in 2020
Figure 40. Global Melanoma Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Melanoma Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Melanoma Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Melanoma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Melanoma Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Melanoma Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Melanoma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Melanoma Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Melanoma Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Melanoma Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Melanoma Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Melanoma Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Melanoma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Melanoma Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Melanoma Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Melanoma Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Melanoma Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…
- 世界の黒色腫治療薬市場規模・現状・予測（2021年-2027年） Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of…
- 世界の黒色腫治療薬市場 2021：企業別、地域別、種類・用途別 The Melanoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の末端黒子型黒色腫治療市場規模・現状・予測（2021年-2027年） Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Market Analysis and Insights: Global Acral Lentiginous Melanoma Treatment Market The global Acral Lentiginous …